Ghose R R, Sampson A
Curr Med Res Opin. 1977;5(2):147-51. doi: 10.1185/03007997709110155.
Nine patients with persistently elevated diastolic blood pressure, exceeding 130 mmHg, received an oral dose of labetalol ranging from 200 mg to 400 mg. In all patients, this produced a significant and gradual decline in recumbent systolic and diastolic blood pressure, unaccompanied by symptoms or complications, with only minor changes in heart rate. Individual variation in the rate of blood pressure fall suggested differences in absorption and first-pass metabolism. It is suggested that the efficacy of oral labetalol merits further investigation in the rapid control of severe hypertension.
9名舒张压持续升高超过130mmHg的患者口服了200毫克至400毫克的拉贝洛尔。在所有患者中,这都使卧位收缩压和舒张压显著且逐渐下降,未伴有症状或并发症,心率仅有轻微变化。血压下降速率的个体差异表明吸收和首过代谢存在差异。有人认为,口服拉贝洛尔在快速控制重度高血压方面的疗效值得进一步研究。